Cepheid's Q2 Revenues Rise 55 Percent as Loss Widens; Lowers '08 Revenue Guidance | GenomeWeb
NEW YORK (GenomeWeb News) – Cepheid reported after the close of the market on Thursday a 55 percent increase in its second-quarter revenues and a 44.2 percent jump in its net loss for the three-month period ended June 30.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.